INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

Stock Information for Purepoint Uranium Group Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Purepoint Uranium Group Inc.

Stanford Medicine's Dr. Pejman Ghanouni Receives RSNA's Cum Laude Award for CAPTAIN Perioperative Data Presentation
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease
Profound Medical Reports Strong Third Quarter 2025 Financial Results
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.